HISTOPATHOLOGICAL STUDY OF SUBACUTE TOXICITY OF CROCUS SATIVUS L. (SAFFRON) STIGMA TOTAL EXTRACT ON LIVER AND KIDNEY TISSUES IN THE RAT

Objective: The medicinal properties attributed to Crocus sativus L. (saffron) are extensive, but saffron taken in large amounts is highly toxic. This study was performed to elucidate the possible toxic effects of total extract of Crocus sativus L. stigma on liver, kidney and some hematological parameters in normal rats. Methods: Male Wistar rats were randomly assigned into four groups of eight animals each. Group 1 was treated with ISS as control and Groups 2 to 4 were treated with total saffron extract administered daily for 2 weeks intraperitoneally in doses of 0.35, 0.70 and 1.05 g/kg, respectively. Body weight of the animals were recorded on the first, 7 and 14 of the experiment Hematological and biochemical parameters were measured on final days of the experiment. Tissue specimens of the liver and kidneys were subjected to histological examination using standard hematoxyline-eosin staining. Results: Total saffron extract caused significant reductions in the Hb and HCT levels and total RBC count, although it showed no dose-dependent effect. Total WBC count showed significant dose-dependent increases in extract treated rats. The extract treated animals, also, exhibited significant dose-dependent increased values of AST, ALT, urea, uric acid and creatinine. In the histopathological studies of liver and kidneys in extract treated rats, there were mild to severe tissue injuries supporting the biochemical analysis. Conclusion: The results of this study indicated that total extract of Crocus sativus L. stigma is toxic (in given doses), and causes hepatic and renal tissue damages along with anemia in rats.

[1]  Hossein Hosseinzadeh,et al.  Crocus Sativus L. (Saffron) Extract and its Active Constituents (Crocin and Safranal) on Ischemia-Reperfusion in Rat Skeletal Muscle , 2007, Evidence-based complementary and alternative medicine : eCAM.

[2]  H. Hosseinzadeh,et al.  Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[3]  S. Akhondzadeh,et al.  Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[4]  M. Nayebpour,et al.  THE EFFECT OF AQUEOUS EXTRACT OF CROUCUS SATIVUS ON THE BASIC AND FUNCTIONAL ELECTROPHYSIOLOGICAL PROPERTIES OF ISOLATED PERFUSED RABBIT AV-NODAL PREPARATION , 2006 .

[5]  H. Sadeghnia,et al.  Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[6]  S. Akhondzadeh,et al.  Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. , 2005, Journal of ethnopharmacology.

[7]  G. Karimi,et al.  EVALUATION OF SUBACUTE TOXICITY OF AQUEOUS EXTRACT OF CROCUS SATIVUS L. STIGMA AND PETAL IN RATS , 2004 .

[8]  S. Akhondzadeh,et al.  Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816] , 2004, BMC complementary and alternative medicine.

[9]  J. J. Espinosa-Aguirre,et al.  Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. , 2004, Cancer detection and prevention.

[10]  J. J. Espinosa-Aguirre,et al.  Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.). , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  M. Fatehi,et al.  Effects of Crocus sativus petals' extract on rat blood pressure and on responses induced by electrical field stimulation in the rat isolated vas deferens and guinea-pig ileum. , 2003, Journal of ethnopharmacology.

[12]  S. Stockham,et al.  Fundamentals of Veterinary Clinical Pathology , 2002 .

[13]  E. Goh,et al.  Evaluation of the developmental toxicity of crocetin on Xenopus. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  H. Hosseinzadeh,et al.  ANTICONVULSANT EFFECTS OF AQUEOUS AND ETHANOLIC EXTRACTS OF CROCUS SATIVUS L. STIGMAS IN MICE , 2002 .

[15]  M. Wichtl Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis , 2001 .

[16]  H. Riese,et al.  Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rat. , 1999, Nutrition and cancer.

[17]  M. Whitehead,et al.  A prospective study of the causes of notably raised aspartate aminotransferase of liver origin , 1999, Gut.

[18]  G. Alonso,et al.  Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. , 1996, Cancer letters.

[19]  S C Nair,et al.  Saffron chemoprevention in biology and medicine: a review. , 1995, Cancer biotherapy.

[20]  M. Manfait,et al.  Inhibition of growth and induction of differentiation of promyelocytic leukemia (HL-60) by carotenoids from Crocus sativus L. , 1994, Anticancer research.

[21]  N. Tietz Fundamentals of Clinical Chemistry , 1970 .

[22]  T. Loomis Essentials of Toxicology , 1968 .